» Authors » John Umejiego

John Umejiego

Explore the profile of John Umejiego including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudin C, Reck M, Johnson M, Blackhall F, Hann C, Yang J, et al.
J Hematol Oncol . 2023 Jun; 16(1):66. PMID: 37355629
Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with a poor prognosis. Initial responses to standard-of-care chemo-immunotherapy are, unfortunately, followed by rapid disease recurrence in most patients. Current...
2.
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree J, et al.
Oncologist . 2022 Aug; 27(11):940-951. PMID: 35983951
Introduction: Neuroendocrine neoplasms (NEN) are heterogeneous malignancies that can arise at almost any anatomical site and are classified as biologically distinct well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas...
3.
Fernandez-Vina M, Wang T, Lee S, Haagenson M, Aljurf M, Askar M, et al.
Blood . 2014 Jan; 123(8):1270-8. PMID: 24408320
In subjects mismatched in the HLA alleles C*03:03/C*03:04 no allogeneic cytotoxic T-lymphocyte responses are detected in vitro. Hematopoietic stem cell transplantation (HSCT) with unrelated donors (UDs) showed no association between...
4.
Hurley C, Woolfrey A, Wang T, Haagenson M, Umejiego J, Aljurf M, et al.
Blood . 2013 May; 121(23):4800-6. PMID: 23637130
The impact of HLA homozygosity at mismatched (MM) loci on the outcome of 2687 myeloablative unrelated donor hematopoietic cell transplantations performed for malignant disease was evaluated among 4 groups: 7/8...